Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8612-8616
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8612
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8612
Pseudotumor/patient | Maximum diameter (mm) | Localization | Vascular involvement | Presence of lymphadenopathy | EUS FNA/adequate sample | Surgery | Final diagnosis |
1 | 35 | Body | Yes | No | Normal/yes | No | CP |
2 | 30 | Head | No | Yes | CP/yes | No | CP |
3 | 20 | Head | No | No | Normal/yes | No | CP |
4 | 35 | Head | Yes | Yes | Inflammation/yes | Yes | CP |
5 | 35 | Neck | No | No | CP/yes | No | CP |
6 | 28 | Body | No | No | CP/yes | No | CP |
7 | 30 | Neck | No | Yes | Non-neoplastic cells/yes | Yes | Myofibroblastic tumor |
8 | 40 | Head | Yes | Yes | Normal/yes | Yes | Pancreatic cancer |
9 | 40 | Head | Yes | Yes | CP/yes | Yes | Pancreatic cancer |
- Citation: Téllez-Ávila FI, Villalobos-Garita &, Giovannini M, Chan C, Hernández-Calleros J, Uscanga L, Ramírez-Luna M&. Follow-up of patients with pseudotumoral chronic pancreatitis: Outcome and surveillance. World J Gastroenterol 2014; 20(26): 8612-8616
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8612.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8612